• Increase font size
  • Default font size
  • Decrease font size
home | about us | contact us
Search
Search Only:

Search Keyword heb

Total: 50 results found.

... detection of influenza viruses, as well as a dedicated women's health panel. This will allow diagnostic andresearchaccesstothebroadestcommercially available PCR-based assay portfolio in the marketplace. Thesystem ...
... people and processes as well as technology.” To learn more and register for the webinars, go to http://www.reinventthebusinessofcare.com. About McKesson McKesson Corporation, currently ranked 14th ...
... Goodman -- VicePresident and Director of Information Technology, Crescent State Bank inCary, NC. Goodman joined the bank in 2008 with the mission to upgrade thebank's technologies with new cost saving ...
... Followingpre-BLAdiscussionswith theFDA,Pharmingis preparing the BLA dossierfor submission towards theend of this yearbut no later than January 2011. TheBLAwillbebasedonthedata of the European Marketing Authorization ...
... been previously treated. The company also announced today that the application has been granted a priority review designation by the FDA. Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that its ...
... dans les domaines des sciences de la vie, physiques, chimiques et appliquées et de la médecine clinique. BioPharma Dealmakers est une nouvelle newsletter électronique bihebdomadaire qui offre du ...
National experts offer insight on suicide as the third-leading cause of death for America's youths ages 15-24 SHEBOYGAN, ...
... in the first quarter of 2010, in addition to $1.6 million from four new provincial markets including Jiangsu, Jiangxi, Chongqing and Hebei province. Another notable contributor from Biostar's portfolio ...
... an exclusive license to Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, to commercialize Acetadote in Australia. In April 2010, the Therapeutics Goods Administration (TGA), which ...
... of its existing plant nutrient production line from 10,000 tons to 15,000 tons. -- In July, the Company acquired the Shengmingsu distribution network from its provincial level distributor in Hebei Province ...
... as well as to petroleum wholesalers and individual retail gas stations. The Company has seven production facilities, located in the Sichuan, Hebei, Fujian and Hunan provinces and in Beijing, Shanghai and ...
... and PER.C6®technologies, using adenovirus serotype26 (rAd26) as vector, and is jointlydevelopedbyCrucellandtheBIDMC,funded by a grant from the US NationalInstitute ofAllergy andInfectious Diseases,part ...
... Powers at Powers Taylor, LLP, toll free, 877-728-9607, via e-mail at patrick@cptlawfirm.com, or The Briscoe Law Firm, PLLC, toll free, 877-397-5991, or via email at WBriscoe@TheBriscoeLawFirm.com. There ...
...  Also attending this year's event are the Hebni Nutrition Consultants, creators of the Soul Food Pyramid™, who will conduct onsite diabetes-friendly ...
... or via email at WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you. The Briscoe Law Firm is a full service business litigation, commercial transaction, and public advocacy firm with more ...
... at WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you. The Briscoe Law Firm is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years ...
... LightInTheBox.com Product Makes Summer Awesome!' Journalists and Bloggers Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds ...
... IV Therapy company Grifols S.A., and to install the first-ever Cancer Therapy Robot in Spain at Vall d'Hebron University Hospital in Barcelona in November 2010.  ...
... San Francisco Office; Hires New Senior Staff Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital Other ...
... San Francisco Office; Hires New Senior Staff Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital Other ...
... San Francisco Office; Hires New Senior Staff Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital Journalists ...
... San Francisco Office; Hires New Senior Staff Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital Other ...
... San Francisco Office; Hires New Senior Staff Health Robotics' CytoCare Continues European Expansion With Grifols and Vall d'Hebron University Hospital Other ...
... lead product Ruconest foracute HAE attacks, its clinical development for follow-on indications in the field of transplantation and making Pharmingfinancially sustainableon thebasis offuture revenuesfrom these priority ...
... erhalten hatten. Hervorzuheben ist, dass die höhere Unterscheidungsfähigkeit des T-SPOT.TB Tests im Vergleich mit dem Tuberkulin-Hauttest im Wesentlichen auf seine höhere Sensitivität zurückzuführen ...
... Bristolhas expanded and extendedthissuccessfulrelationshipintootherstrongareas of BioFocus expertise." "Moleculesfrom theBioFocus collectionhave shownpromise in amplifying the therapeuticproperties ofgalanin ...
27. Arch Biopartners Launches Website
(News/Breaking News)
... applications include: Modifying Biocompatibility (i.e. to improve thebody's ability to accept and interact with implants and other non-biologicmedical devices) Changing the corrosive ...
... Hebrew University of Jerusalem; and Senior Molecular Biologist, New York University Medical Center. He holds a Ph.D. in microbiology from Tel Aviv University. Michael Reidy, Ph.D., is currently Vice ...
... provide a comprehensive overview of the “meaningful use” requirements as they are defined under the final rule. The webinar will be presented by Muhammad Chebli, Vice President of Information Technology ...
... and, in China, Herbalife sales employees, on the principles of nutrition, physical activity and healthy lifestyle. The board is chaired by David Heber, M.D., Ph.D., director of the Center for Human ...
... Company licenses its PER.C6® technology and other proprietary technologies tothebiopharmaceuticalindustry.Importantpartners and licensees include Johnson& Johnson, DSM Biologics, sanofi-aventis, ...
... have joined Poxel's board of directors:ThierryHercend,MD,PhD,andChairmanoftheBoard; Raphaël Wisniewski,Partner at EdRIP; Olivier Martinez,PhD, Investment Manager at the InnoBioFund and Bruno Montanari, ...
... acquisition of the distribution network in Hebei province, which is comprised of a customer list of all county-level distributors who sell the Company's Shengmingsu plant and animal nutrient products to ...
...  http://www.thebody.com/content/art57219.html About GeoVax Labs, Inc.  ...
... potato chips, cookies, crackers and baked snacks. "The results thus far are very positive andshould be well received by thebaking industry, an industry that is already seeking and testing ways to reduce ...
... or The Briscoe Law Firm at (214) 706-9314, or via email at WBriscoe@TheBriscoeLawFirm.com. There is no cost or fee to you. The Briscoe Law Firm is a business litigation, commercial transaction, and ...
... Statements Thispressreleasecontains forward-lookingstatementsaboutthebusiness, goals an prospects of Chiasma, Inc., including, without limitation, statements about the development of drugs in the TPE ...
... animal nutrient products in China, today announced that it has entered into an agreement to acquire the Shengmingsu distribution network from its provincial level distributor in Hebei Province which is ...
... Visitors will also be invited to enjoy a live, interactive cooking demonstration with the Hebni Nutrition Consultants, creators of "The New Soul Food Pyramid."  ...
... worden uitgevoerd die baat zouden kunnen hebben bij een behandeling met het Prevena System. Dat komt neer op een potentiële kans van ruim 1 miljard dollar wereldwijd. Het product zal begin juli beschikbaar ...
... in thebrain's"striatopallidalpathway".mGluR5are found abundantlyin the striatum and areimplicated in the excess glutamate activity inParkinson's Disease. Research shows that inhibition of glutamate stimulation inthis ...
... capital team.  Ron received an M.B.A. from Harvard University and joint Master of Public Health and M.D. degrees from Hebrew University.  ...
... short-term trials withhealthy subjects (ozone challenge) andin patients with Asthma and COPD," said Prof Wolfgang Meyer-Sabellek, Chief MedicalOfficer of Revotar. "Weare now looking forwardto confirm and extend thisencouragingpotentialonthebasisoflonger ...
... normal body weight and avoiding tobacco use can prevent or delay the onset of diabetes Type-2Diabetesresultsfromthebody'sineffective use of insulin. Type-2 Diabetescomprises 90% of people with diabetes ...
... development, manufacturing and distribution of narcotic and pain-management products, today announced that Hebei Aoxing, its sole operating subsidiary, has completed a bank loan financing with China Citic ...
... is being conducted in collaboration with Professor Hermona Soreq, from the Hebrew University in Jerusalem, Israel, a world leader in the field of acetylcholinesterase research.  The production of ...
... liver are associated with poor prognosis for patients, and new therapies are clearly needed,” said Josep Tabernero, M.D., Head of the Gastrointestinal Cancer and Phase I Program at Vall d’Hebron ...
... and new therapies are clearly needed,” said Josep Tabernero, M.D., Head of the Gastrointestinal Cancer and Phase I Program at Vall d’Hebron University Hospital in Barcelona, Spain. “The initial ...
... June 6 by Dr. Irene Brana from Vall d’Hebron University Hospital in Barcelona, Spain. The study is evaluating the safety, tolerability, and clinical activity of continuous daily dosing of XL765 administered ...
... PER.C6(®) production technology. The Company licenses its PER.C6(®) technology and other technologies tothebiopharmaceutical industry.Importantpartners and licensees include Johnson& Johnson, DSM Biologics, ...

Get Free Email and Phone News Alerts

* Your email address:
* Preferred Format:
* Enter the security code shown:
 
Home | Privacy Policy
© 2010 BioMedReports.com. All rights reserved